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INTRODUCTION 
Integrins are the primary receptors used by cells to 
interact with extracellular matrix. Both ECM and integrins 
play an important part in the survival, proliferation and 
death of cells. When an injury occurs in hmg epithelial 
cells signals through the integrins could significantly 
effect whether disease or repair occur. 
Laminin attaches to a number of integrins including 
al~l, a2~1, a3~1, a6~1, CX7 ~1 and a6~4 [1-4l. Various ~1 and ~4 
integrin complexes were shown to be involved in the 
activation of a number of cell eyelin inhibitorS[5-7]. 
a6~4 was shown to activate p53 flUlction in carcinoma 
cells[8] and p53 was fOWld to inhibit a6~4 integrin survival 
signalling[9l. The ~4 integrin cytoplasmic domain was 
shown to be involved in the activation of p21 pathways 
of growth arrest and apoptosis[5l. T cell proliferation in 
the human thymus was fOWld to be controlled via a6~4 by 
laminin 5 Vivinus-Nebot et aZ.[4l . 
a5~j, a fibronectin binding integrin, was fOWld to 
negatively regulate cell growth in the absence of 
attachment to fibronectin[lol. a5~1 was reported to be 
involved in the expression of tumour suppressor p16INK4a 
upon loss of anchorage (anoikis) in a number of human 
cancer cells[lll and also supports survival of cells by 
up-regulating Bcl-2 expression[12l. Trypsin was also fOWld 
to stimulate integrin a5~1 dependent adhesion to 
fibronectin[13l. a6~1 was shown to be an essential step 
accompanyIng the neoplastic transformation of 
hepatocytes[14l. 
MATERIALS AND METHODS 
Clara cell isolation and culturing: Mice (C3H1He strain 
or p21 ko mice either male or female, between 4 to 8 weeks 
old) were sacrificed by lethal intraperitoneal injection of 
O.5ml penlabarbitone (Sagalal™). p21 ko mice wee kindly 
provided by Dr. Philip Leder, Harvard Medical Shool, 
Boston. Clara cells were isolated and cultured as 
previously described[15l. 
Once isolated, cell were plated onto 16-well glass 
chamber slides (Gibco) which had been pre-coated with 
appropriate laminin (50)lg mL) and incubated at 37c C, 5% 
CO/air. Cells were allowed to attach overnight after which 
the medium was replaced to remove dead and Wlattached 
cells. Medium was subsequently replaced every 2 days. 
Cells were usually fixed at days 1, 3 and 5 by 
methanol at-20°e. 
Culture medium: Mouse bronchiolar cells were cultured 
in a 1:1 mixture of Hams Fl2 (Gibco) and M-I99 medium 
(Gibeo) supplemented with 2 mM L-glutamine, 10 )lg mL 
insulin, 5 ).lg mL transferrin, 100 ng mL hydrocortisone, 
lOng rnL EGF, 0.1 ng mL retinly acetate and Pen/Strep'''] 
Integrin blocking experiments: Clara cells from both wt 
and p21 ko mice were cultured on Laminin at a 
concentration of 50 ).lg mL and incubated with either a 
~, blocking antibody (Hm~,) or with a cytokeratin 
8 antibody as a control. Both antibodies were used at a 
concentration of 1 0 ).lg mL. The ~l integrin antibody was 
obtained as a gift from Prof. Hideo Yagita, Department of 
ImmWlology, JWltendo University School of Medicine, 
Tokyo, Japan. This antibody is now commercially 
available from PharMingen (Catalogue No. 553837). The 
HM~l antibody has been shown previously to react with 
mouse ~l and has an inhibitory effect on cell adhesion to 
ECM proteins this IS a fWlctional ~l blocking 
antibody''''>'] The cytokeratin 8 antibody (10526 ICN) 
does not have an inhibitory fWlction. 
Immunocyto/histo-chemistry: Slides were equilibrated in 
TBS for 5 min. Please note that the work slides refer 
cytospins, tissue sections as well as cultured cells. The 
slides were block with an adequate serum in which the 
secondary antibody was raised. Primary antibody at a 
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Table 1 
Antibody 
Li,t of antibody us ed with detail> of concentration u£ed, 
,uppli er and c<talo gu e numb er 
Concentrition 
1/10 
1/100 
1/200 
Supplier 
DAKO 
Vector Loo 
SIGMA 
Catalogue 
numb er 
M7207 
N:L-p53·CM~ 
P20n 
concentration specified in the Table 1 was applied for 
2 h, followed by three 5 min washes with 1BST. 
Secondary antibody was put on foc 30 min then washed 
three times for 5 min each with 1BST. An Alexa 
conjugated secondary antibody (diluted 1:200 in serum) 
was put on the slide and incubated for 3 min. The 
slides were then washed three times foc 5 min each 
and mounted using DAKO fluorescent mounting 
medium. The slides were then visualised either llllder 
fluorescent microscope. 
RESULTS 
TIrree cyclin kinase inhibitors p21, p27 and p53 were 
studied by immunocytochemistry (Fig. 1,2,3,4). 
The expressioo of cytqllasmic p21 increased (P<0.05) 
upon beta-l integrin blocking at 120 h in culture. The 
expression of nuclear p21 increased (P<0.05) upoo beta-l 
integrin blocking at 72 and 120 h in culture. The 
expression of nuclear p21 increased (p<0.05) in culture 
from time 24 to 120 h upon beta-l integrin blocking. 
A decrease (p<0.05) in the expression of cytqllasmic p27 
was obseIVed in cells from wt mice at 24 h in culture and 
in cells from p21 ko mice in all time points in culture, upoo 
beta-l integrin blocking. A significant increase (p<0.05) 
in the nuclear p27 expression was obseIVed in cells from 
p21 ko mice at 24 h and in cells from wt mice at 72 h in 
culture upon beta-lintegrin blocking. 
11~l rn-m ~~ 
24 72 120 
-
The expressioo of nuclear p53 increased significantly 
(p<0.05) in cells from wt and p21 ko mice upon beta-l 
integrin blocking at 72 and 120 h in culture. Upon beta-l 
blocking, there was an increase (p<0.05) in the expressioo 
of nuclear p53 from 24 to 120 h in culture in cells from both 
wt and p21 ko mice. No significant differences in the 
nuclear and cytoplasmic expression of p53 were noted in 
Clara cells from wt mice when compared to p21 ko mice. 
No significant changes in the eX[Kession of cytoplasmic 
p53 were observed upon beta-l integrin blocking in cells 
from both wt and p21 ko mice. 
DISCUSSION 
Nucltar p21 and p53 txprusion incnast upon bda-l 
inttgIin blocking in clara cdls cultun: Upoo beta-l 
integrin blocking, an increase (p<0.05) in the nuclear p21 
expression was obseIVed in Clara cells. p21 expressioo 
was previously shown to be increased by the beta-4 
cytoplasmic domain. Lower levels of 1l6P. surface 
expressioo were shown to induce p21 sufficient to induce 
partial Gl arrest and some apoptosis, while higher levels 
of a,;P. expressioo resulted in more p21 expression and 
more widespread apoptotic deathI5J. Thus in this study, 
due to the fact that beta-l integrin was blocked, there 
could have been a hypothetical increase in either the 
expression of ilJ34 or relatively more IlJ3. integrin 
adhered to an mice. The expression of cytoplasmic p21 
increased (p<0.05) upon beta-l integrin blocking at 120 h 
in culture [graph (A), control (not beta-l integrin blocked) 
at 120 h (C), beta-l blocked cells at 120 h (D)]. The 
expression of nuclear p21 increased (P<0.05) upoo beta-l 
integrin blocking at 72 and 120 h in culture (B) [graph (B), 
control (not beta-l integrin blocked) at 120 h (C), beta-l 
integrin blocked cells at 120 h (D)]. The expression of 
lOOl _p21 1~ Jl 
24 n 120 
-
Fig. 1: Changes in the expression of p21 upon beta-l integrin blocking in Clara cells frOOl wt and p21 ko 
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Fig. 2: Changes p27 and p.53 expressioo upon beta-l integrin blocking in Clara cells from wt and p21 ko mice. Upon beta-l 
integrin blocking, there was a decrease (p<0.05) in the eX[Kession of cytqllasmic p27 was observed in cells frem 
wt mice at 24 h in culture and in cells frOOl p21 ko mice in all time point in culture (A). A significant increase 
(p<0.05) in the nuclearp27 expressioo was obseIVedin cells from p21 ko mice at 24 h and in cells from wt mice at 
72 h in culture upon beta-l blocking (B). No significant changes in the expression of cytoplasmic p53 were 
obseIVed upon beta-l blocking in cells from both wt and p21 ko mice (C). The expression of nuclear p53 increased 
significantly (P<0.05) in cells from wt and p21 ko mice upon beta-l integrin blocking at 72 and 120 h in culture. An 
increase (p<o.05) in the expression of nuclear p53 was observed from 24 to 120 h in culture in cells from both wt 
and p21 ko mice (D) 
Fig. 3: Changes in p27 expression upon beta-l integrin blocking in Clara cells from wt and p21 ko mice. Upon beta-l 
integrin blocking, there was a decrease (p<0.05) in the expression of cytoplasmic p27 in cells from wt mice at 
24 h in culture (A andB) and in cells from p21 ko mice at all time points in culture (cells from at 120 h in culture 
are represented in C and D). A significant increase (p<0.05) in the nuclear p27 eX[Kession was observed in cells 
from p21 ko mice at 24 h (E and F) and in cells from wt mice at 72 h (G and H) in culture upon beta-l blocking. [A, 
C, E and G are cells frOOl control (not beta-l blocked, while B, D, F and H are beta-l blocked cells]. I represent the 
negative cootrol for immunofluorescence whereby the [Kimary antibody was omitted. Magnificatioo x 200 
nuclear p21 increased (p<0.05) in culture from time 24 to 
120 h upon beta-l integrin blocking [graphs (A and B), 
beta-l blocked cells at 24 h (E), beta-l blocked cells at 120 
hr(D)]. F is a typical negative control for 
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immunofluorescence whereby the [Kimary antibody was 
omitted. Magnificatioo x 200 appropriate receptor and 
thus results in an increase in p21. More work needs to be 
carried out, to find out the exact mechanism by which p21 
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Fig. 4: Changes in p53 expression upon beta-l integrin blocking in Clara cells from wt and p21 ko mice. Upon beta-l 
integrin blocking, the expression of nuclear p53 increased significantly (p<0.05) in cells from wt mice (A and B) 
and in cells from p21 ko mice (C and D) at 120 h in culture. An increase (p<0.05) in the expression of nuclear p53 
was observed from 24 (E) to 120 (D) h in culture in cells from p21 ko mice. No significant changes in the 
expression of cytoplasmic p53 were observed upon beta-l integrin blocking in cells from both wt and p21 ko 
mice (A - E). [A and C are cells from control (not beta-l integrin blocked, while B, D and E are beta-l blocked 
cells]. F is the negative control for immwlOfluorescence whereby the primary antibcxly was omitted. 
Magnification x 200 
expression increases upon beta-l integrin blocking. The 
literature about this topic is so far very limited. Upon beta-
1 integrin blocking, the nuclear p53 expression increased 
(p<0.05) in Clara cells from both wt and p21 ko mice. a6 ~4 
was shmvn to activate p53 Bachelder et al.[81, whereas p53 
itself was fOlllld to inhibit a6 ~4 integrin survival 
signalling[91. The reason for the increase in the nuclear 
p53 could be the same as for the p21, but whether the 
increase ofp21 is dependent or independent ofp53 is not 
known. 
In this study no significant differences in the nuclear 
and cytoplasmic expression ofp53 were observed in Clara 
cells in the presence or absence of p21 upon beta-l 
blocking. It seems that apart from beta-l and beta-4 
integrins, other integrins are involved, possibly beta-3, 
beta-6 or beta-7. Although beta-3 was fOlllld not to be 
present in lllllg epithelium cells[151 but beta-3 expression 
was fOlllld to be present in the epithelial cells of fibrotic 
lungs[191. Beta-3 integrin was shown to be involved in the 
p53 and p21 expressions (20)11. av complexes either to ~3. ~5 
or ~8 were also fOlllld to be involved in the expression of 
p53 and p21(22)31. Thus, it can be hypothesised that the 
increase in p53 expression in the absence ofp21 could be 
mediated via integrins, but further studies have to be 
canied out to detennine which integrins are involved and 
to detennine the exact mechanism. 
P27 translocation to the nucleus occurs faster in the 
absence of p21 upon beta-l integrin in clara cells: Upon 
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beta-l integrin blocking, there was a decrease (p<0.05) in 
the expression of cytoplasmic p27 at all time points in 
culture. An increase in nuclear p27 expression in cells 
from p21 ko mice at 24 h and in cells from wt mice at 72 
h in culture, were observed upon beta-l integrin blocking. 
Thus upon beta-l integrin blocking, the translocation of 
p27 from the cytoplasm to the nucleus seems to be faster 
in the absence of p21. It has previously been 
hypothesised that p27 expression could be influenced via 
beta-l integrin[24-261, but the exact mechanism is still 
llllclear and the literature so far is quite limited. Thus 
further studies need to be canied out to describe the 
relationship ofp27 with integrins. 
CONCLUSION 
When cells are attached to a6 ~4' p21 is not involved 
in the cytokeratins 8, 18 and 19 expressions of Clara cells , 
while when cell-a6 ~4 interaction is disturbed the presence 
ofp21 is important for the cytokeratins expression. Cell-
beta-l interactions could also be involved in the 
cytokeratins expressions. Therefore the expression levels 
of p21 could be a detenninant factor in Clara cell 
differentiation. Cell-beta 1 interactions were described as 
a potential factor in cell proliferation. The lack of binding 
of beta-l integrin to an appropriate receptor could lead to 
a decrease in cell proliferation. Beta-l integrin disruption 
could also lead to an increase in PCNA expression but for 
an increase in nuclear PCN A p21 was shown to be an 
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essential factor. Upon blocking beta-l integrin there is an 
increased nuclear expression of p21, p27 and p53 and an 
mcrease III apoptosis rate. Thus as originally 
hypothesised, integrins that bind to laminin are important 
for cell cycle progression through p21-dependent or 
independent mechanisms. 
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